BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 26319969)

  • 1. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
    Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
    Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heavy/light chain assay in the monitoring of multiple myeloma.
    Ting HY; Sthaneshwar P; Bee PC; Shanmugam H; Lim M
    Pathology; 2019 Aug; 51(5):507-511. PubMed ID: 31253381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays.
    Katzmann JA; Willrich MA; Kohlhagen MC; Kyle RA; Murray DL; Snyder MR; Rajkumar SV; Dispenzieri A
    Clin Chem; 2015 Feb; 61(2):360-7. PubMed ID: 25451866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Hevylite™ IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia.
    Paolini L; Di Noto G; Maffina F; Martellosio G; Radeghieri A; Luigi C; Ricotta D
    Ann Clin Biochem; 2015 May; 52(Pt 3):337-45. PubMed ID: 25468997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases.
    Dogaru M; Lazăr V; Coriu D
    Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.
    Ludwig H; Milosavljevic D; Zojer N; Faint JM; Bradwell AR; Hübl W; Harding SJ
    Leukemia; 2013 Jan; 27(1):213-9. PubMed ID: 22955329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M; Lazăr V; Coriu D
    Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal Heavy/Light Chain Ratio and Matched Pair Suppression Increase Residual Disease Detection Sensitivity in Patients With Multiple Myeloma With Deep Responses.
    Miyazaki K; Suzuki K
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):293-296. PubMed ID: 29472112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathy.
    Wolff F; Debaugnies F; Rozen L; Willems D; Brohet F; Brauner J; Stordeur P
    Clin Biochem; 2013 Jan; 46(1-2):79-84. PubMed ID: 23041246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the noninvolved pair of the myeloma isotype correlates with poor survival in newly diagnosed and relapsed/refractory patients with myeloma.
    Ludwig H; Milosavljevic D; Berlanga O; Zojer N; Hübl W; Fritz V; Harding S
    Am J Hematol; 2016 Mar; 91(3):295-301. PubMed ID: 26662888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).
    van de Donk NW; Otten HG; El Haddad O; Axel A; Sasser AK; Croockewit S; Jacobs JF
    Clin Chem Lab Med; 2016 Jun; 54(6):1105-9. PubMed ID: 26812873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
    Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
    Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.
    Bradwell AR; Harding SJ; Fourrier NJ; Wallis GL; Drayson MT; Carr-Smith HD; Mead GP
    Clin Chem; 2009 Sep; 55(9):1646-55. PubMed ID: 19617289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies.
    Harding SJ; Mead GP; Bradwell AR; Berard AM
    Clin Chem Lab Med; 2009; 47(3):302-4. PubMed ID: 19676141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients.
    Bradwell A; Harding S; Fourrier N; Mathiot C; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
    Leukemia; 2013 Jan; 27(1):202-7. PubMed ID: 22699454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of β region IgA paraproteins - should we include immunochemical "heavy/light chain" measurements? Counterpoint.
    Paolini L
    Clin Chem Lab Med; 2016 Jun; 54(6):1059-64. PubMed ID: 26812795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin heavy chain/light chain pairs (HLC, Hevylite™) assays for diagnosing and monitoring monoclonal gammopathies.
    Kraj M
    Adv Clin Exp Med; 2014; 23(1):127-33. PubMed ID: 24596015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heavy/light chain assay as a biomarker for diagnosis and follow-up of multiple myeloma.
    Chae H; Han E; Yoo J; Lee J; Lee JJ; Cha K; Kim M; Kim Y; Lee SE; Min CK
    Clin Chim Acta; 2018 Apr; 479():7-13. PubMed ID: 29324245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.